Tarceva Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Real World Study on Erlotinib Combined With Bevacizumab in First Line EGFR Mutation Positive Advanced Non-aquamous Non-small Cell Lung Cancer
Condition:   Efficacy and Safety of Erlotinib Combined With Bevacizumab in EGFR Mutation Positive Advanced Non-squamous Non-small Cell Lung Cancer Intervention:   Drug: erlotinib combined with Bevacizumab Sponsor:   Hunan Province Tumor Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2018 Category: Research Source Type: clinical trials

Real World Study on Erlotinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Condition:   Efficacy and Safety of Erlotinib Combined With Bevacizumab in EGFR Mutation Positive Advanced Non-squamous Non-small Cell Lung Cancer Intervention:   Drug: erlotinib combined with Bevacizumab Sponsor:   Hunan Province Tumor Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2018 Category: Research Source Type: clinical trials